CRI Worldwide and Lifetree Clinical Research Announce New Company Name: CRI Lifetree
CRI Worldwide, a specialized research organization conentating in psychiatry, pediatrics, pain, and neurology, which recently acquired Lifetree Clinical Research, has united the two companies under the new name, CRI Lifetree. Accompanying the new name is its strategically focused tagline, “Innovative Solutions. Reliable Results.”
The company integrates CRI’s experience in psychiatry and expertise in complex studies with Lifetree’s clinical trial management and site expertise in Phase I-III pain management and abuse liability studies. Bringing the companies together under one unified name streamlines all branding, communication, and SOPs and processes across the two companies.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
